Maertens JA, Thompson GR 3rd, Spec A, Donovan FM, et al. Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study. Lancet Infect Dis 2025 Jun 17:S1473-3099(25)00224.
PMID: 40541222